We have previously shown that Tfm mice which have a non-functional androgen receptor (AR) and low endogenous levels of testosterone exhibit increased fatty streak formation within the aortic root. The aim of the present study was to administer varying degrees of testosterone to these animals in comparison to littermate controls to determine the role of the AR in the anti-atherogenic action of testosterone.
Eight-week-old Tfm mice (n=24) and XY littermates (n=16) were placed into 5 groups which received a fortnightly 10 μl i.m injection of either saline, Sustanon100 (S100) or Sustanon250 (S250). At ten weeks of age all mice were fed a cholesterol-enriched diet for 28-weeks. Mice were sacrificed, the hearts perfused with saline and frozen at −80°C. Five, 8 micrometre cryosections were taken at 100 micrometre intervals through the aortic root of each heart. Sections were stained with oil red O and counterstained with haematoxylin and lipid-stained areas quantified via digital analysis, and expressed as percentage of medial area.
|AR/Testosterone Status||Lipid Deposition (% medial area)|
|Tfm saline||AR deficient/low testosterone||2.86 (0.39)|
|XY saline||AR intact/physiological testosterone||0.44 (0.09)|
|Tfm S100||AR deficient/physiological testosterone||0.37 (0.14)a|
|Tfm S250||AR deficient/supra-physiological testosterone||1.25 (0.20)a,b|
|XY S250||AR intact/supra-physiological testosterone||0.22 (0.17)|
|aP<0.001 versus Tfm saline, bP<0.05 versus Tfm S100|
Aortic fatty-streak formation is significantly reduced in AR-deficient Tfm mice receiving physiological testosterone replacement and to a lesser extent supra-physiological testosterone therapy. Testosterone induces anti-atherogenic effects via a non-genomic mechanism.
01 - 05 Apr 2006
European Society of Endocrinology